Ep910: Keren Leshem | CEO and Board Director, OCON healthcare

Keren Leshem is currently OCON healthcare's CEO and board director. A leading women's health BioTech company with a mission to introduce innovative intrauterine drug-delivery technology for various conditions and diseases to improve and impact women's health and quality of life.

Before OCON, Ms Leshem headed the Corporate Development team at the European pharma company VISUfarma.

In addition, she was a board member of a BioLight (TASE: BOLT) company: ViSci (which she previously headed as CEO) and an Open University lecturer in Marketing & Business English.
As the founder & CEO of ViSci Ltd (Licensed from NASDAQ: AERI) amongst other positions in Pharma and MedTech, Ms Leshem successfully led Clinical, R&D and BD activities to achieve commercial status and MTAs (Material Transfer Agreements) in the USA, EU and China.

Ms Leshem was recently featured in FORBES magazine and sits on FemTech Lab's admissions and advisory Board as well as LSX's Advisory Board, and is a Mentor at the 8400 Health Network.

Ms Leshem makes sure to lead with passion and integrity and donate her time and earnings to and with women entrepreneurs starting their career paths and those who have made choices that require mentoring.